HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome

Oral Oncology

Volumn 48, Issue 11, 2012, Pages 1178-1184

  Tribius, Silke ^a   Hoffmann, Anna S ^a   Bastrop, Sophie ^b   Görögh, Tibor ^b   Haag, Jochen ^b   Röcken, Christoph ^b   Clauditz, Till ^a   Grob, Tobias ^a   Wilczak, Waldemar ^a   Tennstedt, Pierre ^a   Borcherding, Aileen ^a   Petersen, Cordula ^a   Hoffmann, Markus ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Cancer of unknown primary; Head and neck cancer; Human papillomavirus; Occult primary cancer

Indexed keywords

CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FORMALDEHYDE; PARAFFIN; PROTEIN P16; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENOTYPING TECHNIQUE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECURRENCE FREE SURVIVAL; SMOKING; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SURVIVAL RATE; TIME FACTORS;

EID: 84867847724     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.05.022     Document Type: Article

References (48)

1. C. Grau, L.V. Johansen, J. Jakobsen, P. Geertsen, E. Andersen, and B.B. Jensen Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology Radiother Oncol 55 2 2000 121 129
2. R. Feinmesser, I. Miyazaki, R. Cheung, J.L. Freeman, A.M. Noyek, and H.M. Dosch Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration N Engl J Med 326 1 1992 17 21
3. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Occult primary (cancer of unknown primary [CUP]). Version 2. 2011. < http://www.nccn.org/professionals/physician-gls/pdf/occult.pdf >.
4. T. Kaprealian, and S.S. Yom Management of the neck and unknown primary of the head and neck E.K. Hansen, M. Roach III Handbook of evidence-based radiation oncology 2010 Springer New York, NY pp. 207-8
5. N. Pavlidis, E. Briasoulis, and G. Pentheroudakis ESMO Guidelines Working Group. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 Suppl. 5 2010 v228 v231
6. D.J. Sher, T.A. Balboni, R.I. Haddad, C.M. Norris Jr., and M.R. Posner Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck Int J Radiat Oncol Biol Phys 80 5 2011 1405 1411
7. J.S. Smith, L. Lindsay, B. Hoots, J. Keys, S. Franceschi, and R. Winer Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update Int J Cancer 121 3 2007 621 632
8. N. Termine, V. Panzarella, S. Falaschini, A. Russo, D. Matranga, and L. Lo Muzio HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007) Ann Oncol 19 10 2008 1681 1690
9. S. Begum, M.L. Gillison, T.L. Nicol, and W.H. Westra Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck Clin Cancer Res 13 4 2007 1186 1191
10. S.K. El-Mofty, M.Q. Zhang, and R.M. Davila Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma Head Neck Pathol 2 3 2008 163 168
11. P.C. Desai, M.V. Jaglal, P. Gopal, S.J. Ghim, D.M. Miller, and H. Farghaly Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: a retrospective 7 year study Exp Mol Pathol 87 2 2009 94 98
12. M. Hoffmann, A. Orlamünder, J. Sucher, S. Gottschlich, T. Görögh, and A. Fazel HPV16 DNA in histologically confirmed tumour-free neck lymph nodes of head and neck cancers Anticancer Res 26 1B 2006 663 670
13. 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study Head Neck 30 4 2008 471 478
14. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary Chin Med J (Engl) 124 7 2011 1010 1014
15. L. Rudmik, H.Y. Lau, T.W. Matthews, J.D. Bosch, R. Kloiber, and C.P. Molnar Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial Head Neck 33 7 2011 935 940
16. J.S. Park, J.J. Yim, W.J. Kang, J.K. Chung, C.G. Yoo, and Y.W. Kim Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT BMC Res Notes 4 2011 56
17. 18F-fluorodeoxyglucose positron emission tomography/computed tomography Cancer Biother Rad 26 3 2011 331 334
18. R.K. Saiki, S. Scharf, F. Faloona, K.B. Mullis, G.T. Horn, and H.A. Erlich Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for the diagnosis of sickle cell anemia Science 230 4732 1985 1350 1354
19. J.J. van Dongen, A.W. Langerak, M. Brüggemann, P.A. Evans, M. Hummel, and F.L. Lavender Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936 Leukemia 17 12 2003 2257 2317
20. + primer sets J Clin Virol 30 4 2004 302 308
21. GenBank Basic Local Alignment Search Tool (BLAST) server. < http://blast.ncbi.nlm.nih.gov/Blast.cgi >.
22. R. Klaes, T. Friedrich, D. Spitkovsky, R. Ridder, W. Rudy, and U. Petry Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri Int J Cancer 92 2 2001 276 284
23. Globocan Project 2008. < http://globocan.iarc.fr/ >.
24. K. Hu, L.B. Harrison, R.A. Shourbaji, B. Culliney, Z. Li, and W.F. Mourad Outcomes of occult primary (OP) of the head and neck squamous cell carcinoma (HNSCC) treated with oropharynx (OPX)-targeted radiotherapy (RT) and concurrent chemotherapy (CCRT) J Clin Oncol 2012 30 [suppl; abstr 5559]
25. S. Begum, M.L. Gillison, M.A. Ansari-Lari, K. Shah, and W.H. Westra Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin Clin Cancer Res 9 17 2003 6469 6475
26. M. Śnietura, M. Jaworska, W. Pigłowski, A. Goraj-Zaja̧c, G. Woźniak, and D. Lange High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx Pol J Pathol 61 3 2010 133 139
27. M. Hoffmann, S. Tribius, E.S. Quabius, H. Henry, S. Pfannenschmidt, and C. Burkhardt HPV DNA, E6()I-mRNA expression and p16(INK4A) immunohistochemistry in head and neck cancer - how valid is p16(INK4A) as surrogate marker? Cancer Lett 323 1 2012 88 96
28. K.J. Elango, A. Suresh, E.M. Erode, L. Subhadradevi, H.K. Ravindran, and S.K. Iyer Role of human papilloma virus in oral tongue squamous cell carcinoma Asian Pac J Cancer Prev 12 4 2011 889 896
29. A.D. Singhi, and W.H. Westra Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience Cancer 116 9 2010 2166 2173
30. E. Rotnáglová, R. Tachezy, M. Saláková, B. Procházka, E. Košl'abová, and E. Veselá HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers Int J Cancer 129 1 2011 101 110
31. G. Pannone, V. Rodolico, A. Santoro, L. Lo Muzio, R. Franco, and G. Botti Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, consensus PCR HPV-DNA, and in situ hybridization Infect Agent Cancer 7 2012 4
32. N. Yanagawa, G. Tamura, H. Oizumi, N. Takahashi, Y. Shimazaki, and T. Motoyama Frequent epigenetic silencing of the p16 gene in non-small cell lung cancers of tobacco smokers Jpn J Cancer Res 93 10 2002 1107 1113
33. M.G. Fury, M. Drobnjak, C.S. Sima, M. Asher, J. Shah, and N. Lee Tissue microarray evidence of association between p16 and phosphorylated eIF4E in tonsillar squamous cell carcinoma Head Neck 33 9 2011 1340 1345
34. K.K. Ang, J. Harris, R. Wheeler, R. Weber, D.I. Rosenthal, and P.F. Nguyen-Tân Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 1 2010 24 35
35. M. Knoedler, A. Zakarneh, U. Zimmermann, K. Woelke, O. Kaschke, and U. Keilholz Effects of human papillomavirus (HPV) and other potential risk factors on survival in patients with oropharyngeal cancer J Clin Oncol 29 15S 2011 [abstr 5577]
36. D.T. Huang, C.R. Johnson, R. Schmidt-Ullrich, and M. Grimes Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study Int J Radiat Oncol Biol Phys 23 4 1992 737 742
37. S.H. Huang, B. O'Sullivan, I. Weinreb, B. Perez-Ordonez, J. Irish, and J. Waldron Patterns of failure and histopathologic outcome predictors following definitive radiotherapy and planned neck dissection with residual disease Head Neck 2011 September 26. [Epub ahead of print]
38. J. Bernier, J.S. Cooper, T.F. Pajak, M. van Glabbeke, J. Bourhis, and A. Forastiere Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) Head Neck 27 10 2005 843 850
39. S. Marur, G. D'Souza, W.H. Westra, and A.A. Forastiere HPV-associated head and neck cancer: a virus-related cancer epidemic Lancet Oncol 11 8 2010 781 789
40. J.M. Straetmans, N. Olthof, J.J. Mooren, J. de Jong, E.J. Speel, and B. Kremer Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas Laryngoscope 119 10 2009 1951 1957
41. INK4a overexpression predicts translational active human papillomavirus infection in tonsillar cancer Int J Cancer 127 7 2010 1595 1602
42. A. Näsman, P. Attner, L. Hammarstedt, J. Du, M. Eriksson, and G. Giraud Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125 2 2009 362 366
43. P. Attner, J. Du, A. Nasman, L. Hammarstedt, T. Ramqvist, and J. Lindholm The role of human papillomavirus in the increased incidence of base of tongue cancer Int J Cancer 126 12 2010 2879 2884
44. Tsiodras S, Spathis A, Chranioti A, Panayiotides J, Pappas A, Kassanos D, et al. Geographical variation of HPV infection rates in a sample of 1728 women in Greece. Annual meeting of the Infectious Diseases Society of America 2010. < https://idsa.confex.com/idsa/2010/webprogram/Paper4311.html > [abstract 687].
45. J. Acs, A. Hildesheim, W.C. Reeves, M. Brenes, L. Brinton, and C. Lavery Regional distribution of human papillomavirus DNA and other risk factors for invasive cervical cancer in Panama Cancer Res 49 20 1989 5725 5729
46. T. Nyári, I. Cseh, M. Woodward, J. Szöllösi, M. Bak, and J. Deák Screening for human papillomavirus infection in asymptomatic women in Hungary Hum Reprod 16 10 2001 2235 2237
47. A.R. Kreimer, G.M. Clifford, P. Boyle, and S. Franceschi Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review Cancer Epidemiol Biomarkers Prev 14 2 2005 467 475
48. S.J. Smeets, A.T. Hesselink, E.J. Speel, A. Haesevoets, P.J. Snijders, and M. Pawlita A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen Int J Cancer 121 11 2007 2465 2472